LOADING

Advancing regenerative
medicine Targeting Myocardial Infarction
& Heart Failure

HIGHLIGHTS

1 / 5

HIGHLIGHTS

2 / 5

HIGHLIGHTS

3 / 5

HIGHLIGHTS

4 / 5

HIGHLIGHTS

5 / 5

Our Vision

Myocardial Regeneration
The ultimate goal of clinical cardiology

Regencor's team envisions a future where myocardial infarctions no longer impose incurable & life threatening tissue damage or progression to heart failure

Regencor's Technology

Q-Beads: A true game-changer in heart disease therapy

Our recombinant protein, delivered subcutaneously, reverses the formation of scar tissue. Scar tissue is the most serious complication after a myocardial infarction as it weakens the heart and leads to progressive heart failure.

LEADERSHIP

Thomas Okarma - Chairman, President & CEO of Regencor

Thomas Okarma, MD, PhD
Chairman, President & CEO

Pilar Ruiz-Lozano - Chief Scientific Officer at Regencor

Pilar Ruiz-Lozano, PhD
Chief Scientific Officer

Mark Mercola - Director at Regencor

Mark Mercola, PhD
Director